skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

15370

Complete response of a metastatic gastroesophageal adenocarcinoma on irinotecan-based chemotherapy in a dialysis patient



Case report

(4199) Total Article Views


Authors: J Verwimp, F Geurs, S Ponette, et al

Published Date May 2010 Volume 2010:3 Pages 61 - 64
DOI: http://dx.doi.org/10.2147/IJNRD.S7650

J Verwimp1, F Geurs1, S Ponette2, J Ponette2, J Martens3, K Bulté2

1Department of Medical Oncology, 2Department of Gastroenterology, 3Department of Nephrology, Regionaal Ziekenhuis Sint-Maria, Ziekenhuislaan, Halle, Belgium

Abstract: We present the first case report of a complete response of metastatic gastroesophageal cancer in a chronic hemodialysis patient with irinotecan-based chemotherapy. An elderly dialysis patient presented with diffuse liver metastases by a gastroesophageal adenocarcinoma. He received combination chemotherapy with 5 fluorouracil and irinotecan. After six months of chemotherapy, liver scans show complete remission. The principles, practice, and experience of chemotherapy with irinotecan during dialysis are discussed.

Keywords: gastroesophageal cancer, irinotecan, chemotherapy, dialysis




Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter

 

Other articles by Dr Filip Geurs


Readers of this article also read: